Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 360 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
2019
Venetsanaki, V., Karabouta Z., & Polyzos S. A. (2019).  Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.. Eur J Pharmacol. 863, 172661.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Anastasilakis, A. D., Koulaxis D., Upadhyay J., Pagkalidou E., Kefala N., Perakakis N., et al. (2019).  Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.. Horm Metab Res. 51(2), 112-119.
Kountouras, J., Doulberis M., Papaefthimiou A., & Polyzos S. A. (2019).  Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.. Ann Gastroenterol. 32(3), 318.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.. Helicobacter. 24(3), e12588.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?. Metabolism. 96, iii-v.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology.. J Clin Gastroenterol.
Kountouras, J., Doulberis M., Polyzos S. A., Katsinelos T., Vardaka E., Kountouras C., et al. (2019).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.. Alzheimers Dement. 15(5), 723-725.
Papaefthymiou, A., Doulberis M., Katsinelos P., Liatsos C., Polyzos S. A., Kotronis G., et al. (2019).  Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress.. Ann N Y Acad Sci.
Papaefthymiou, A., Doulberis M., Kountouras J., Kolokytha C., Galanopoulos M., Liatsos C., et al. (2019).  Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.. Eur J Gastroenterol Hepatol.
Kountouras, J., Papaefthymiou A., Doulberis M., & Polyzos S. A. (2019).  Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk.. Liver Int.
Anastasilakis, A. D., Polyzos S. A., Makras P., Douni E., & Mantzoros C. S. (2019).  Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?. Metabolism. 93, 100-102.
Venetsanaki, V., & Polyzos S. A. (2019).  Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.. Curr Vasc Pharmacol. 17(6), 546-555.
Kountouras, J., Doulberis M., Polyzos S. A., & Katsinelos P. (2019).  Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease.. Ann Gastroenterol. 32(2), 214.
Katsinelos, T., Doulberis M., Polyzos S. A., Papaefthymiou A., Katsinelos P., & Kountouras J. (2019).  Molecular links between Alzheimer's disease and Gastrointestinal microbiota with its-related metabolic syndrome: emphasis on Helicobacter pylori infection involvement.. Curr Mol Med.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Perakakis, N., Polyzos S. A., Yazdani A., Sala-Vila A., Kountouras J., Anastasilakis A. D., et al. (2019).  Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study.. Metabolism. 154005.
Polyzos, S. A., Slavakis A., Koumerkeridis G., Katsinelos P., & Kountouras J. (2019).  Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.. Horm Metab Res. 51(2), 134-140.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.. Metabolism. 92, 82-97.
Polyzos, S. A., & Mantzoros C. S. (2019).  Obesity: seize the day, fight the fat.. Metabolism. 92, 1-5.
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2019).  Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?. Metabolism. 96, vi-xi.
Polyzos, S. A., Makras P., Tournis S., & Anastasilakis A. D. (2019).  Off-label uses of denosumab in metabolic bone diseases.. Bone. 129, 115048.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzivras D., et al. (2019).  A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.. Ann N Y Acad Sci. 1452(1), 12-17.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές